Skip to main content

Table 1 Clinical characteristics and concomitant mutations of patients with RAS/BRAFV600E mutant colorectal cancer

From: Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan

  1. tub1/tub2 tubular adenocarcinoma, por poorly differentiated adenocarcinoma, sig signet-ring cell carcinoma, muc mucinous adenocarcinoma, MSS Microsatellite stable, MSI-H Microsatellite instability-high, EGFR Epidermal growth factor receptor, VEGF Vascular endothelial growth factor, HR Hazard ratio; P-value: Fisher’s exact test, and the value of the comparison between this group and other groups
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us